Chiquita Brooks-LaSure

Food is medicine, you know, from former First Lady Michelle Obama to certainly the Biden-Harris administration really focused on trying to think more broadly about health. I would say that what concerns me the most is some of the fundamental things that government needs to do

Food is medicine, you know, from former First Lady Michelle Obama to certainly the Biden-Harris administration really focused on trying to think more broadly about health. I would say that what concerns me the most is some of the fundamental things that government needs to do

In the HHS reorg and eliminating of so many of our federal workers, we are in danger of seeing really serious public health outcomes. occur that that the government needs to be monitoring. And we just got out of a pandemic. Thank goodness. Right. But there are other things coming down the pike. There is an important an important role for our public health agencies to make sure they're tracking.

In the HHS reorg and eliminating of so many of our federal workers, we are in danger of seeing really serious public health outcomes. occur that that the government needs to be monitoring. And we just got out of a pandemic. Thank goodness. Right. But there are other things coming down the pike. There is an important an important role for our public health agencies to make sure they're tracking.

In the HHS reorg and eliminating of so many of our federal workers, we are in danger of seeing really serious public health outcomes. occur that that the government needs to be monitoring. And we just got out of a pandemic. Thank goodness. Right. But there are other things coming down the pike. There is an important an important role for our public health agencies to make sure they're tracking.

I think we talked at the beginning about innovation, and when we think about the NIH grants and so many of the other changes to funding, I am deeply worried about our our scientists, our clinicians, who are doing research across this world, not just the country, but across this world, and what that impact is gonna be for our health overall.

I think we talked at the beginning about innovation, and when we think about the NIH grants and so many of the other changes to funding, I am deeply worried about our our scientists, our clinicians, who are doing research across this world, not just the country, but across this world, and what that impact is gonna be for our health overall.

I think we talked at the beginning about innovation, and when we think about the NIH grants and so many of the other changes to funding, I am deeply worried about our our scientists, our clinicians, who are doing research across this world, not just the country, but across this world, and what that impact is gonna be for our health overall.

So I would say, you know, some of the things that are being proposed, no issue with them, very supportive, but we don't wanna do the nice to have or good idea and forget the essential, necessary, and we're seeing just some of the beginnings with the measles.

So I would say, you know, some of the things that are being proposed, no issue with them, very supportive, but we don't wanna do the nice to have or good idea and forget the essential, necessary, and we're seeing just some of the beginnings with the measles.

So I would say, you know, some of the things that are being proposed, no issue with them, very supportive, but we don't wanna do the nice to have or good idea and forget the essential, necessary, and we're seeing just some of the beginnings with the measles.

But it's, again, when I think of the pipeline, just talking to people in cancer research, what we're seeing in our clinical trials, I am very worried for that aspect of our future.

But it's, again, when I think of the pipeline, just talking to people in cancer research, what we're seeing in our clinical trials, I am very worried for that aspect of our future.

But it's, again, when I think of the pipeline, just talking to people in cancer research, what we're seeing in our clinical trials, I am very worried for that aspect of our future.

Well, thank you for this conversation. I think it's quite timely and I would just say that I think really focusing on the changes that are coming, that Congress is considering, We really need to put it in context. We left the Biden administration having the lowest uninsured rate in our U.S. history.

Well, thank you for this conversation. I think it's quite timely and I would just say that I think really focusing on the changes that are coming, that Congress is considering, We really need to put it in context. We left the Biden administration having the lowest uninsured rate in our U.S. history.

Well, thank you for this conversation. I think it's quite timely and I would just say that I think really focusing on the changes that are coming, that Congress is considering, We really need to put it in context. We left the Biden administration having the lowest uninsured rate in our U.S. history.

We had reached record levels of enrollment and people in strengthening the Medicaid program and then lowering prescription drug costs, which has really changed people's lives and just really hope that we continue to see that progress forward because affordable drugs This is the, among one of the most important healthcare issues facing our nation.

We had reached record levels of enrollment and people in strengthening the Medicaid program and then lowering prescription drug costs, which has really changed people's lives and just really hope that we continue to see that progress forward because affordable drugs This is the, among one of the most important healthcare issues facing our nation.

We had reached record levels of enrollment and people in strengthening the Medicaid program and then lowering prescription drug costs, which has really changed people's lives and just really hope that we continue to see that progress forward because affordable drugs This is the, among one of the most important healthcare issues facing our nation.